{
	"@context": {
		"rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
		"dct": "http://purl.org/dc/terms/",
		"owl": "http://www.w3.org/2002/07/owl#",
		"xsd": "http://www.w3.org/2001/XMLSchema#",
		"rdfs": "http://www.w3.org/2000/01/rdf-schema#",
		"@vocab": "http://ld.nice.org.uk/ns/bnf#",
		"bnf": "http://ld.nice.org.uk/ns/bnf/",
		"nicebnf": "http://ld.nice.org.uk/ns/bnf#",
		"route": "http://ld.nice.org.uk/ns/bnf/Route#",
		"patientGroup": "http://ld.nice.org.uk/ns/bnf/PatientGroup#",
		"indication": "http://ld.nice.org.uk/ns/bnf/Indication#",
		"sideEffect": "http://ld.nice.org.uk/ns/bnf/SideEffect#",
		"classification": "http://ld.nice.org.uk/ns/bnf/Classification#",
		"isLinkedFrom": {
			"@container": "@set"
		},
		"hasInteraction": {
			"@container": "@set"
		},
		"hasMessage": {
			"@container": "@set"
		},
		"hasInteractionList": {
			"@container": "@set"
		},
		"isInteractionListOf": {
			"@container": "@set"
		}
	},
	"@graph": [
		{
			"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2",
			"@type": "InteractionList",
			"hasInteraction": [
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699773",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699773_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"acebutolol\" outputclass=\"int-drug\">acebutolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  acebutolol  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "1",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Acebutolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699774",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699774_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"alectinib\" outputclass=\"int-drug\">alectinib</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  alectinib  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "2",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Alectinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699775",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699775_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"alfentanil\" outputclass=\"int-drug\">alfentanil</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  alfentanil  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "3",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Alfentanil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699776",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699776_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"amikacin\" outputclass=\"int-drug\">amikacin</ph> have neuromuscular blocking effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  amikacin  have neuromuscular blocking effects. \n\n"
						}
					],
					"hasOrder": "4",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Amikacin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699777",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699777_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"amiodarone\" outputclass=\"int-drug\">amiodarone</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  amiodarone  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "5",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Amiodarone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699778",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699778_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"apraclonidine\" outputclass=\"int-drug\">apraclonidine</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  apraclonidine  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "6",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Apraclonidine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699779",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699779_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"atenolol\" outputclass=\"int-drug\">atenolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  atenolol  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "7",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Atenolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699780",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699780_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"beclometasone\" outputclass=\"int-drug\">Beclometasone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Beclometasone   is predicted to   decrease   the effects of   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "8",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Beclometasone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699781",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699781_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"betamethasone\" outputclass=\"int-drug\">Betamethasone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Betamethasone   is predicted to   decrease   the effects of   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "9",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Betamethasone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699782",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699782_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"betaxolol\" outputclass=\"int-drug\">betaxolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  betaxolol  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "10",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Betaxolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699783",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699783_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"bisoprolol\" outputclass=\"int-drug\">bisoprolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  bisoprolol  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "11",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bisoprolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699784",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699784_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"botulinum toxin type A\" outputclass=\"int-drug\">botulinum toxin type A</ph> have neuromuscular blocking effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  botulinum toxin type A  have neuromuscular blocking effects. \n\n"
						}
					],
					"hasOrder": "12",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Botulinum toxin type A</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699785",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699785_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"botulinum toxin type B\" outputclass=\"int-drug\">botulinum toxin type B</ph> have neuromuscular blocking effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  botulinum toxin type B  have neuromuscular blocking effects. \n\n"
						}
					],
					"hasOrder": "13",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Botulinum toxin type B</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699786",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699786_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"brimonidine\" outputclass=\"int-drug\">brimonidine</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  brimonidine  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "14",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Brimonidine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699787",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699787_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"budesonide\" outputclass=\"int-drug\">Budesonide</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Budesonide   is predicted to   decrease   the effects of   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "15",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Budesonide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699788",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699788_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"carbamazepine\" outputclass=\"int-drug\">Carbamazepine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of (but acute use increases the effects of)</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor and adjust dose</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Carbamazepine   is predicted to   decrease   the effects of (but acute use increases the effects of)   cisatracurium .  Manufacturer advises monitor and adjust dose .    \n\n"
						}
					],
					"hasOrder": "16",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Carbamazepine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699789",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699789_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"carvedilol\" outputclass=\"int-drug\">carvedilol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  carvedilol  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "17",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Carvedilol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699790",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699790_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"celiprolol\" outputclass=\"int-drug\">celiprolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  celiprolol  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "18",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Celiprolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699791",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699791_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"ciclesonide\" outputclass=\"int-drug\">Ciclesonide</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Ciclesonide   is predicted to   decrease   the effects of   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "19",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ciclesonide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699792",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699792_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"clindamycin\" outputclass=\"int-drug\">Clindamycin</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Clindamycin   increases   the effects of   cisatracurium .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "20",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Clindamycin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699793",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699793_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"clonidine\" outputclass=\"int-drug\">clonidine</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  clonidine  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "21",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Clonidine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699794",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699794_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"colistimethate\" outputclass=\"int-drug\">colistimethate</ph> have neuromuscular blocking effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  colistimethate  have neuromuscular blocking effects. \n\n"
						}
					],
					"hasOrder": "22",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Colistimethate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699795",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699795_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"crizotinib\" outputclass=\"int-drug\">crizotinib</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  crizotinib  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "23",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Crizotinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699796",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699796_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"deflazacort\" outputclass=\"int-drug\">Deflazacort</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Deflazacort   is predicted to   decrease   the effects of   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "24",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Deflazacort</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699797",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699797_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"dexamethasone\" outputclass=\"int-drug\">Dexamethasone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Dexamethasone   is predicted to   decrease   the effects of   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "25",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dexamethasone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699798",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699798_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"digoxin\" outputclass=\"int-drug\">digoxin</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  digoxin  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "26",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Digoxin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699799",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699799_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"diltiazem\" outputclass=\"int-drug\">diltiazem</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  diltiazem  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "27",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Diltiazem</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699800",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699800_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"donepezil\" outputclass=\"int-drug\">donepezil</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  donepezil  can increase the risk of bradycardia. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699800_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"donepezil\" outputclass=\"int-drug\">Donepezil</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Donepezil   is predicted to   decrease   the effects of   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "28",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Donepezil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699801",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699801_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"esmolol\" outputclass=\"int-drug\">esmolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  esmolol  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "29",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Esmolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699802",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699802_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"fentanyl\" outputclass=\"int-drug\">fentanyl</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  fentanyl  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "30",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fentanyl</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699803",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699803_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"fingolimod\" outputclass=\"int-drug\">fingolimod</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  fingolimod  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "31",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fingolimod</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699804",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699804_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"flecainide\" outputclass=\"int-drug\">flecainide</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  flecainide  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "32",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Flecainide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699805",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699805_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"fludrocortisone\" outputclass=\"int-drug\">Fludrocortisone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Fludrocortisone   is predicted to   decrease   the effects of   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "33",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fludrocortisone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699806",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699806_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"fluticasone\" outputclass=\"int-drug\">Fluticasone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Fluticasone   is predicted to   decrease   the effects of   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "34",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fluticasone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699807",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699807_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"fosphenytoin\" outputclass=\"int-drug\">Fosphenytoin</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the effects of (but acute use increases the effects of)</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Fosphenytoin   decreases   the effects of (but acute use increases the effects of)   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "35",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fosphenytoin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699808",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699808_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"galantamine\" outputclass=\"int-drug\">galantamine</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  galantamine  can increase the risk of bradycardia. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699808_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"galantamine\" outputclass=\"int-drug\">Galantamine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Galantamine   is predicted to   decrease   the effects of   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "36",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Galantamine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699809",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699809_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"gentamicin\" outputclass=\"int-drug\">gentamicin</ph> have neuromuscular blocking effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  gentamicin  have neuromuscular blocking effects. \n\n"
						}
					],
					"hasOrder": "37",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Gentamicin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699810",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699810_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"hydrocortisone\" outputclass=\"int-drug\">Hydrocortisone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Hydrocortisone   is predicted to   decrease   the effects of   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "38",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Hydrocortisone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699811",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699811_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"irinotecan\" outputclass=\"int-drug\">Irinotecan</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Irinotecan   is predicted to   decrease   the effects of   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "39",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Irinotecan</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699812",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699812_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"ivabradine\" outputclass=\"int-drug\">ivabradine</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  ivabradine  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "40",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ivabradine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699813",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699813_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"labetalol\" outputclass=\"int-drug\">labetalol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  labetalol  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "41",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Labetalol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699814",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699814_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"levobunolol\" outputclass=\"int-drug\">levobunolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  levobunolol  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "42",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Levobunolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699815",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699815_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-drug\">magnesium</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   increases   the effects of   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "43",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Magnesium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699816",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699816_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"methadone\" outputclass=\"int-drug\">methadone</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  methadone  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "44",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Methadone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699817",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699817_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"methylprednisolone\" outputclass=\"int-drug\">Methylprednisolone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Methylprednisolone   is predicted to   decrease   the effects of   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "45",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Methylprednisolone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699818",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699818_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"metoclopramide\" outputclass=\"int-drug\">Metoclopramide</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Metoclopramide   is predicted to   increase   the effects of   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "46",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Metoclopramide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699819",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699819_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"metoprolol\" outputclass=\"int-drug\">metoprolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  metoprolol  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "47",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Metoprolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699820",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699820_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"mometasone\" outputclass=\"int-drug\">Mometasone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Mometasone   is predicted to   decrease   the effects of   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "48",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Mometasone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699821",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699821_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"nadolol\" outputclass=\"int-drug\">nadolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  nadolol  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "49",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nadolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699822",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699822_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"nebivolol\" outputclass=\"int-drug\">nebivolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  nebivolol  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "50",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nebivolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699823",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699823_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"neomycin\" outputclass=\"int-drug\">neomycin</ph> have neuromuscular blocking effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  neomycin  have neuromuscular blocking effects. \n\n"
						}
					],
					"hasOrder": "51",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Neomycin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699824",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699824_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"neostigmine\" outputclass=\"int-drug\">neostigmine</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  neostigmine  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "52",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Neostigmine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699825",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699825_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"oxprenolol\" outputclass=\"int-drug\">oxprenolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  oxprenolol  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "53",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Oxprenolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699826",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699826_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"pasireotide\" outputclass=\"int-drug\">pasireotide</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  pasireotide  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "54",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pasireotide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699827",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699827_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"phenytoin\" outputclass=\"int-drug\">Phenytoin</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the effects of (but acute use increases the effects of)</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Phenytoin   decreases   the effects of (but acute use increases the effects of)   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "55",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Phenytoin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699828",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699828_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"pindolol\" outputclass=\"int-drug\">pindolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  pindolol  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "56",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pindolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699829",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699829_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"piperacillin\" outputclass=\"int-drug\">Piperacillin</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Piperacillin   increases   the effects of   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "57",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Piperacillin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699830",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699830_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"polymyxins\" outputclass=\"int-drug\">polymyxins</ph> have neuromuscular blocking effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  polymyxins  have neuromuscular blocking effects. \n\n"
						}
					],
					"hasOrder": "58",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Polymyxins</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699831",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699831_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"prednisolone\" outputclass=\"int-drug\">Prednisolone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Prednisolone   is predicted to   decrease   the effects of   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "59",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Prednisolone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699832",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699832_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"propranolol\" outputclass=\"int-drug\">propranolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  propranolol  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "60",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Propranolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699833",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699833_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"pyridostigmine\" outputclass=\"int-drug\">pyridostigmine</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  pyridostigmine  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "61",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pyridostigmine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699834",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699834_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"remifentanil\" outputclass=\"int-drug\">remifentanil</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  remifentanil  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "62",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Remifentanil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699835",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699835_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"rivastigmine\" outputclass=\"int-drug\">rivastigmine</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  rivastigmine  can increase the risk of bradycardia. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699835_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-drug\">Rivastigmine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Rivastigmine   is predicted to   decrease   the effects of   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "63",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Rivastigmine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699836",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699836_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"selegiline\" outputclass=\"int-drug\">selegiline</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  selegiline  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "64",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Selegiline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699837",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699837_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"sotalol\" outputclass=\"int-drug\">sotalol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  sotalol  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "65",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sotalol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699838",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699838_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"streptomycin\" outputclass=\"int-drug\">streptomycin</ph> have neuromuscular blocking effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  streptomycin  have neuromuscular blocking effects. \n\n"
						}
					],
					"hasOrder": "66",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Streptomycin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699839",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699839_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"sufentanil\" outputclass=\"int-drug\">sufentanil</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  sufentanil  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "67",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sufentanil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699840",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699840_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"suxamethonium\" outputclass=\"int-drug\">suxamethonium</ph> have neuromuscular blocking effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  suxamethonium  have neuromuscular blocking effects. \n\n"
						}
					],
					"hasOrder": "68",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Suxamethonium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699841",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699841_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"thalidomide\" outputclass=\"int-drug\">thalidomide</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  thalidomide  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "69",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Thalidomide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699842",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699842_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"timolol\" outputclass=\"int-drug\">timolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  timolol  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "70",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Timolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699843",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699843_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"tizanidine\" outputclass=\"int-drug\">tizanidine</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  tizanidine  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "71",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tizanidine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699844",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699844_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"tobramycin\" outputclass=\"int-drug\">tobramycin</ph> have neuromuscular blocking effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  tobramycin  have neuromuscular blocking effects. \n\n"
						}
					],
					"hasOrder": "72",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tobramycin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699845",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699845_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"triamcinolone\" outputclass=\"int-drug\">Triamcinolone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Triamcinolone   is predicted to   decrease   the effects of   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "73",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Triamcinolone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699846",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2#bnf_i1557280699846_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"cisatracurium\" outputclass=\"int-heading-drug\">cisatracurium</ph> and <ph otherprops=\"verapamil\" outputclass=\"int-drug\">verapamil</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  cisatracurium  and  verapamil  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "74",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Verapamil</title>"
					}
				}
			],
			"hasSearchLabel": " Cisatracurium  | Interactions",
			"hasSearchLink": {
				"@id": "http://bnf.nice.org.uk/interaction/cisatracurium-2.html"
			},
			"hasTitle": {
				"@type": "rdf:XMLLiteral",
				"@value": "<title> Cisatracurium </title>"
			},
			"rdfs:label": "cisatracurium"
		}
	]
}